|
Volumn 6, Issue 7, 2015, Pages 1318-1327
|
Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (3 AMINO 4 METHOXYBENZYLIDENE) 5,6,7 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
2 (3 BROMO 4 METHOXYBENZYLIDENE) 4,5,6 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
2 (3 FLUORO 4 METHOXYBENZYLIDENE) 4,5,6 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
2 (3 FLUORO 4 METHOXYBENZYLIDENE) 5,6,7 TRIMETHOXY 3,4 DIHYDRONAPHTHALEN 1(2H) ONE;
2 (3 HYDROXY 4 METHOXYBENZYLIDENE) 4,5,6 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
2 (3 HYDROXY 4 METHOXYBENZYLIDENE) 5,6,7 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
2 (3,4 DIMETHOXYBENZYLIDENE) 4,5,6 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
4 (2,3,4 TRIMETHOXYPHENYL)BUTANOIC ACID;
4 OXO 4 (2,3,4 TRIMETHOXYPHENYL)BUTANOIC ACID;
4,5,6 TRIMETHOXY 2 (2,3,4 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
4,5,6 TRIMETHOXY 2 (3,4,5 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
4,5,6 TRIMETHOXY 2 (4 METHOXY 3 NITROBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
4,5,6 TRIMETHOXY 2 (4 METHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
4,5,6 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6 DIMETHOXY 2 (2,3,4 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6 DIMETHOXY 2 (3,4,5 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6 DIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6,7 TRIMETHOXY 2 (3,4,5 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6,7 TRIMETHOXY 2 (4 METHOXY 3 NITROBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6,7 TRIMETHOXY 2 (4 METHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6,7 TRIMETHOXY 2 (4 METHOXYBENZYLIDENE) 3,4 DIHYDRONAPHTHALEN 1(2H) ONE;
5,6,7 TRIMETHOXY 2,3 DIHYDRO 1H INDEN 1 ONE;
5,6,7 TRIMETHOXY 3,4 DIHYDRONAPHTHALEN 1(2H) ONE;
6 HYDROXY 5 METHOXY 2 (2,3,4 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
6 HYDROXY 5 METHOXY 2 (3,4,5 TRIMETHOXYBENZYLIDENE) 2,3 DIHYDRO 1H INDEN 1 ONE;
ANTINEOPLASTIC AGENT;
BENZYLIDENEINDANONE DERIVATIVE;
INDANONE DERIVATIVE;
UNCLASSIFIED DRUG;
A549 CELL LINE;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
ARTICLE;
BEL 7402 CELL LINE;
CANCER INHIBITION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG SYNTHESIS;
G2 PHASE CELL CYCLE CHECKPOINT;
HELA CELL LINE;
HUMAN;
HUMAN CELL;
MDA MB 231 CELL LINE;
MTT ASSAY;
PC 3 CELL LINE;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
|
EID: 84936879571
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c5md00139k Document Type: Article |
Times cited : (20)
|
References (34)
|